Literature DB >> 19523035

Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.

Trinity J Bivalacqua1, Biljana Musicki, Lewis L Hsu, Mark T Gladwin, Arthur L Burnett, Hunter C Champion.   

Abstract

INTRODUCTION: Priapism is a poorly understood disease process with little information on the etiology and pathophysiology of this erectile disorder. One group of patients with a high prevalence of priapism is men with sickle-cell disease. AIM: Establish an in vivo transgenic sickle-cell mouse model to study the pathophysiology of sickle-cell disease-associated priapism.
METHODS: Transgenic sickle-cell disease mice, expressing human sickle hemoglobin, were utilized. Three groups of mice were used: (i) wild type (WT), (ii) sickle-cell heterozygotes (Hemi), and (ii) sickle-cell homozygotes (Sickle). Two age groups of each cohort of mice were utilized: young adult (4-6 months) and aged (18-22 months). MAIN OUTCOME MEASURES: Histological (trichrome stain to measure ratio of collagen to smooth muscle), penile hydroxyproline content (collagen content), and transmission electron microscopic analysis of WT, Hemi, and Sickle mice penes, as well as in vivo erectile responses [change in intracavernous pressure (ICP)] to cavernous nerve stimulation (CNS), were determined. The frequency of erectile responses (erections/hour) pre- and poststimulation was also measured in each of the experimental groups.
RESULTS: Sickle mice had increased (P < 0.05) collagen to smooth muscle ratio and hydroxyproline content in the penis when compared with WT and Hemi mice penes. Transmission electron microscopy demonstrated thickened smooth muscle cell bundles, disruption of the endothelial lining of the corporal sinusoids, and increased (P < 0.05) caveolae number. Sickle mice had significantly (P < 0.05) higher ICP to CNS and increased (P < 0.05) frequency of erections pre- and post-CNS when compared with WT and Hemi mice erectile responses. Sickle mice did develop ED (change in ICP in response to CNS) with increasing age.
CONCLUSION: The morphometric changes of the penis and exaggerated in vivo erectile responses support the use of this transgenic sickle-cell disease animal model to study the pathophysiological mechanisms involved in sickle-cell disease-associated priapism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523035      PMCID: PMC4011713          DOI: 10.1111/j.1743-6109.2009.01359.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  35 in total

1.  Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study.

Authors:  A B Adeyoju; A B K Olujohungbe; J Morris; A Yardumian; D Bareford; A Akenova; O Akinyanju; K Cinkotai; P H O'Reilly
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

2.  American Urological Association guideline on the management of priapism.

Authors:  Drogo K Montague; Jonathan Jarow; Gregory A Broderick; Roger R Dmochowski; Jeremy P W Heaton; Tom F Lue; Ajay Nehra; Ira D Sharlip
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

3.  Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta.

Authors:  B Darblade; D Caillaud; M Poirot; M Fouque; J C Thiers; J Rami; F Bayard; J F Arnal
Journal:  Cardiovasc Res       Date:  2001-06       Impact factor: 10.787

4.  A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.

Authors:  T J Bivalacqua; E K Diner; T E Novak; Y Vohra; S C Sikka; H C Champion; P J Kadowitz; W J Hellstrom
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

5.  Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats.

Authors:  M E Bakircioglu; K D Sievert; L Nunes; A Lau; C S Lin; T F Lue
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

Review 6.  Treatments for priapism in boys and men with sickle cell disease.

Authors:  F Chinegwundoh; K A Anie
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

7.  Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism.

Authors:  Ricardo Munarriz; Kwangsung Park; Yue-Hua Huang; Iñigo Saenz de Tejada; Robert B Moreland; Irwin Goldstein; Abdulmaged M Traish
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

8.  The incidence and management of priapism in Western Australia: a 16 year audit.

Authors:  C M Earle; B G A Stuckey; H L Ching; Z S Wisniewski
Journal:  Int J Impot Res       Date:  2003-08       Impact factor: 2.896

Review 9.  Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.

Authors:  Gregory J Kato; Mark T Gladwin
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

10.  A technique for ultracryotomy of cell suspensions and tissues.

Authors:  K T Tokuyasu
Journal:  J Cell Biol       Date:  1973-05       Impact factor: 10.539

View more
  30 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice.

Authors:  Trinity J Bivalacqua; Ashley E Ross; Travis D Strong; Milena A Gebska; Biljana Musicki; Hunter C Champion; Arthur L Burnett
Journal:  Urology       Date:  2010-06-09       Impact factor: 2.649

Review 3.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

4.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

5.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 6.  Role of adenosine signaling in penile erection and erectile disorders.

Authors:  Prasad V Phatarpekar; Jiaming Wen; Yang Xia
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

7.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

8.  A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation.

Authors:  Jiaming Wen; Almut Grenz; Yujin Zhang; Yingbo Dai; Rodney E Kellems; Michael R Blackburn; Holger K Eltzschig; Yang Xia
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

9.  Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.

Authors:  B Musicki; S Karakus; W Akakpo; F H Silva; J Liu; H Chen; B R Zirkin; A L Burnett
Journal:  Andrology       Date:  2017-11-16       Impact factor: 3.842

Review 10.  Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Authors:  Helen R Levey; Omer Kutlu; Trinity J Bivalacqua
Journal:  Asian J Androl       Date:  2011-11-07       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.